The company owns numerous issued patents and patents pending on this technology, which is designed to make the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems.
OxySure’s efforts are guided by CEO Julian T. Ross, who is also the OxySure founder and technology developer (holds nine patents).
With more than 25 years of experience in technology, manufacturing and finance, Ross has managed development of production capabilities, partnerships and alliances; managed the development of sales, distribution and licensing partnerships; raised in excess of $14 million in debt and equity to fund operations; and took OxySure public in 2011 through an S-1 registration with the Securities and Exchange Commission.
Ross is backed by a highly experienced team of directors and an equally as knowledgeable advisory board. Collectively, the team has experience in healthcare, management, business development, mergers & acquisitions, operations, private practice medicine and more.
For more information, visit www.oxysure.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment